4//SEC Filing
Renaud Ronald C JR 4
Accession 0000899243-23-015539
CIK 0001805387other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:53 PM ET
Size
11.4 KB
Accession
0000899243-23-015539
Insider Transaction Report
Form 4
Renaud Ronald C JR
DirectorPresident & CEO
Transactions
- Award
Restricted Stock Units
2023-06-12+160,452→ 160,452 total→ Common Stock (160,452 underlying) - Award
Stock Option (Right to Buy)
2023-06-12+215,749→ 215,749 totalExercise: $32.72Exp: 2033-06-12→ Common Stock (215,749 underlying) - Award
Performance-based Restricted Stock Units
2023-06-12+160,371→ 160,371 total→ Common Stock (160,371 underlying)
Footnotes (3)
- [F1]25% of this option shall vest and become exercisable on June 12, 2024, with the remainder vesting in thirty-six (36) monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
- [F2]The shares reported in this transaction represent Restricted Stock Units ("RSUs") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments on each of June 12, 2024, June 12, 2025, June 12, 2026 and June 12, 2027, subject to the Reporting Person's continued service on each such vesting date.
- [F3]The shares reported in this transaction represent the target number of performance-based RSUs ("PSUs") granted under the Plan. The PSUs shall vest at the end of a four-year performance period following the Grant Date based on absolute total stockholder return ("TSR") performance measured at the end of the performance period (with a payout range of 0% to 250% of the target number of PSUs, or 50% to 275% of the target number of PSUs upon a Sale Event (as defined in an Employment Agreement between the Issuer and the Reporting Person)), subject to the Reporting Person's continued service at such time. Excludes an additional 160,371 target PSUs issued on the same Grant Date that are subject to vesting based on certain relative TSR performance metrics.
Documents
Issuer
Cerevel Therapeutics Holdings, Inc.
CIK 0001805387
Entity typeother
Related Parties
1- filerCIK 0001354434
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 4:53 PM ET
- Size
- 11.4 KB